Your browser doesn't support javascript.
loading
Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms.
Saracyn, Marek; Durma, Adam Daniel; Bober, Barbara; Kolodziej, Maciej; Lubas, Arkadiusz; Kapusta, Waldemar; Niemczyk, Stanislaw; Kaminski, Grzegorz.
Afiliação
  • Saracyn M; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
  • Durma AD; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
  • Bober B; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
  • Kolodziej M; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
  • Lubas A; Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
  • Kapusta W; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
  • Niemczyk S; Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
  • Kaminski G; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
Nutrients ; 15(1)2022 Dec 30.
Article em En | MEDLINE | ID: mdl-36615845

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Tumores Neuroendócrinos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Tumores Neuroendócrinos Idioma: En Ano de publicação: 2022 Tipo de documento: Article